American Fusion Inc. (OTC: AMFN) has announced the appointment of Dr. Noah D’Amico as a strategic advisor, a move that brings specialized expertise in nuclear diagnostics, radiation measurements, vacuum systems, and AI-assisted particle-track analysis to the company. This appointment comes as American Fusion prepares for the next phase of its Texatron™ Fusion Engine™ testing program at Texas Tech University.
Dr. D’Amico currently serves as lead engineer in Texas Tech University’s Department of Physics & Astronomy and as chief operating officer of BlankSlate Innovation. In his advisory role, he will support laboratory preparation, experimental planning, instrumentation, data collection, and technical documentation. The company stated that his addition strengthens its scientific and engineering capabilities as it continues development and testing of the Texatron fusion platform.
American Fusion is an advanced energy platform company focused on the development and commercialization of next-generation fusion energy technologies. The company is advancing the Texatron™ Fusion Engine™, a neutronic fusion platform designed for modular, infrastructure-grade deployment across industrial, commercial, and grid-constrained applications. The company’s development strategy emphasizes system-level engineering, disciplined intellectual property protection, and scalable architectures intended to support long-term commercial operation, while maintaining a focus on capital discipline and transparent corporate governance.
The appointment of Dr. D’Amico is significant because it brings hands-on expertise from a leading academic institution directly into the company’s testing efforts. His background in nuclear diagnostics and radiation measurements is critical for the rigorous validation of fusion systems. The integration of AI-assisted particle-track analysis also suggests a forward-looking approach to data interpretation, which could accelerate the development timeline.
For more information about American Fusion, visit the company’s newsroom at http://ibn.fm/AMFN.
This strategic move underscores American Fusion’s commitment to advancing its fusion technology with top-tier scientific guidance. As the company progresses with testing at Texas Tech University, the addition of Dr. D’Amico is expected to play a pivotal role in achieving key milestones.
